市場調查報告書

按技術,應用,產品,樣本,區域市場分析,規模,佔有率,趨勢,預測的全球循環腫瘤細胞(CTC)市場(2020-2026)

Circulating Tumor Cells Market, By Technology, By Application, By Product, By Specimen, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026

出版商 AnalystView Market Insights 商品編碼 950955
出版日期 內容資訊 英文 201 Pages
商品交期: 2-3個工作天內
價格
按技術,應用,產品,樣本,區域市場分析,規模,佔有率,趨勢,預測的全球循環腫瘤細胞(CTC)市場(2020-2026) Circulating Tumor Cells Market, By Technology, By Application, By Product, By Specimen, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
出版日期: 2020年06月01日內容資訊: 英文 201 Pages
簡介

全球循環腫瘤細胞(CTC)市場預計在2019年將達到887萬美元,並且從2020年到2026年的複合年增長率為12.8%。通過應用,對臨床和液體活檢的需求有望在未來顯著增長,並且通過設備,各種設備和系統將佔據大部分市場。

該報告分析了全球循環腫瘤細胞(CTC)市場,並定義了市場定義和基本結構,主要市場驅動器/抑製器,行業競爭力/向心力,市場份額結構以及技術/我們正在按應用,產品,樣品和地區(過去5年和未來7年)以及主要公司的概況調查市場趨勢預測。

第1章循環腫瘤細胞市場概述

第2章執行摘要

第3章循環腫瘤細胞(CTC):主要市場趨勢

  • 市場促進因素
    • 市場驅動力影響分析
  • 市場約束因素
    • 市場約束因素的影響分析
  • 市場機會
  • 未來市場趨勢

第4章循環腫瘤細胞(CTC):工業研究

  • 波特的五力分析
  • 營銷策略分析
  • 市場增長前景:映射
  • 監管體系分析
  • 新冠狀病毒感染的影響分析(Covid-19)
    • Covid-19和早期影響分析
    • Covid-19之後的影響分析

第5章循環腫瘤細胞(CTC):市場環境

  • 市場佔有率分析
  • 主要創新公司(innovators)
  • 主要製造商的細分市場數據
    • 現有公司分析
    • 創新公司分析

第6章按技術分類的循環腫瘤細胞(CTC)市場

  • 概述
    • 按技術劃分的市場佔有率分析(2019,2026)
  • CTC分析
  • CTC直接檢測
  • 四氯化碳檢測/濃度

第7章循環腫瘤細胞(CTC)應用市場

  • 概述
  • 研究
  • 臨床/液體活檢(液體活檢)

第8章按產品劃分的循環腫瘤細胞(CTC)市場

  • 概述
  • 設備/系統
  • 採血管
  • 試劑盒和試劑

第9章標本循環腫瘤細胞(CTC)市場

  • 概述
  • 骨髓
  • 血液
  • 其他體液

第10章按地區劃分的循環腫瘤細胞(CTC)市場

  • 簡介
    • 按地區分列的市場份額分析(2019/2026)
  • 北美
    • 概述
    • 北美主要製造商
    • 市場規模和預測:按國家(價值基礎,2015-2026年)
    • 按技術劃分的市場規模和預測(基於金額,2015-2026年)
    • 市場規模和預測:按應用(價值基礎,2015-2026)
    • 市場規模和產品預測(價值基礎,2015-2026)
    • 市場規模和預測:按樣本(價值基礎,2015-2026年)
    • 美國
    • 加拿大
  • 歐洲市場
    • 德國
    • 意大利
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太(APAC)市場
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲市場
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東/非洲市場
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國(UAE)

第11章供應商分析

  • Bio-Techne Corporation
  • Biocept, Inc.
  • ЁЗфЧヱЗ
  • Greiner Bio One International GmbH
  • Precision for Medicine
  • ApoCell, Inc.
  • Aviva Biosciences
  • BioCep, Ltd.
  • Ikonysis, Inc.
  • IVDiagnostics
  • NanoString Technologies, Inc.
  • Canopus Bioscience Ltd.
  • Biolidics Limited
  • Creatv MicroTech, Inc.
  • LungLife AI, Inc.
  • BioFluidica
  • Rarecells Diagnostics
  • Fluxion Biosciences, Inc.
  • Miltenyi Biotec
  • QIAGEN
  • Menarini Silicon Biosystems
  • Epic Sciences
  • ScreenCell
  • Vitatex, Inc.
  • Rarecells Diagnostics
  • Bio-Techne Corporation

第12章分析師的全方位視角

第13章附錄

目錄

Title:
Circulating Tumor Cells Market, By Technology (CTC Analysis, CTC Direct Detection Methods, and CTC Detection & Enrichment Methods), By Application (Research and Clinical/Liquid Biopsy), By Product (Devices or Systems, Blood Collection Tubes, and Kits & Reagents), By Specimen (Bone Marrow, Blood, and Other Body Fluids), and By Geography (NA, APAC, EU, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2020-2026.

REPORT HIGHLIGHT

Circulating tumor cells market was valued at USD 8.87 million by 2019, growing with 12.8% CAGR during the forecast period, 2020-2026.

Circulating tumor cells (CTC) are circulating inside the human body through the lymphatic and blood circulation systems. These cells are useful for understanding disease progression, detection of cancer, and projection of treatment necessary for tumor elimination. Besides, various tumor markers can be used with CTC for cancer diagnosis. CTC testing is widely used in the examination of various types of cancer such as colon cancer, prostate cancer, and breast cancer.

MARKET DYNAMICS

The growing prevalence of cancer all across the globe is the major factor boosting the growth of the global circulating tumor cells (CTC) market. According to Cancer Research UK, there were around 17 million new cases of cancer all over the world in 2018 and this number is estimated to increase up to 27.5 million by 2040. The four most common type of cancer occurring worldwide includes lung, breast, prostate, and bowel cancer. Furthermore, rising demand for efficient diagnostic & screening tests and advancements in technologies for cancer detection are the important driving factors for this industry.

However, reluctance for the adoption of technologically advanced CTC and lack of awareness amongst people are predicted to hamper the market growth in the coming future. Conversely, innovation in CTC technologies and the rising demand for faster diagnostics are expected to offer lucrative growth opportunities in the overall market during the forecast period.

TECHNOLOGY TAKEAWA

"CTC detection & enrichment methods segment to be most lucrative during the forecast period"

Based on technology, the global CTC market is categorized into CTC analysis, CTC direct detection methods, and CTC detection & enrichment methods. The CTC direct detection methods segment is further sub-categorized into microscopy and SERS. Whereas, the CTC detection & enrichment methods are further sub-categorized into combined methods, density-based separation, size-based separation, and immunocapture.

The CTC detection & enrichment methods segment accounted for the largest market share in 2019 and is anticipated to lead the market during the forecast period. This majorly owing to the high usage rates of this technology method in biotechnology research & developments, cancer detection, and high accuracy evinced by this technology. The advancements of enhanced CTCs enable their functional depiction, which is crucial for disease interrogation as well as target therapy. Thus leads to increased demand for enrichment technology. In addition, the growing preference for companion diagnostics coupled with high demand for CTC detection assays will propel the segmental market growth in the coming years.

APPLICATION TAKEAWA

"Clinical & liquid biopsy segment to witness significant growth by 2026"

On the basis of application, the worldwide CTC market is bifurcated into research and clinical &liquid biopsy. The research segment is further sub-categorized into drug & therapy development and cancer stem cell & tumorigenesis research. Whereas, the clinical & liquid biopsy segment is further sub-categorized into screening & monitoring and risk assessment.

The clinical & liquid biopsy segment accounted for the majority of share in the market in 2019 and is expected to grow at a significant rate during the forecast period. This is mainly because the CTC-based screening & monitoring methods are at the promising stage. However, a significant number of commercial tests of liquid biopsy are based on cf-DNA (cell-free DNA) and the dominance of cf-DNA over CTC in cancer diagnosis has hampered the clinical application share in the market. On the contrary, due to the real-time advantages and noninvasiveness of CTC screening, various research groups and companies are taking initiatives to expand the application in clinical settings for tumor cells. This will likely fuel the growth of the clinical & liquid biopsy segment in the projected timeframe.

PRODUCT TAKEAWA

"Devices or systems segment to hold the majority of market share in the forecast period"

Based on the product, the overall market for CTC is categorized into devices or systems, blood collection tubes, and kits & reagents. Among these, the devices or systems segment registered for the highest market share in 2019 and is anticipated to continue this trend during the period of forecast. The presence of a wide portfolio for devices and systems along with forthcoming advances in microfluidics technology are helping this segment to maintain a leading position in the market. In addition, the advancement of automated instruments that helps in eliminating the use of added blood collection tubes is propelling the segmental market growth.

On the other side, the kits & reagents segment is also estimated to contribute to a significant market share in terms of revenue owing to its high usage rate and frequent purchase rate. Moreover, various cancer cell lines have been tested by numerous researchers and a group of researchers with the help of kits offered in the space. This is mainly because these kits are easy to use and the resultant product is subsequently used in downstream analysis.

Specimen Takeaway

"Blood segment to hold the highest market share by 2026"

Based on the specimen, the worldwide market is categorized into bone marrow, blood, and other body fluids. Of these, the blood segment accounted for the largest market share in 2019 and is expected to grow at a considerable rate during the forecast period. This is mainly because a large number of CTC cells are present in blood samples as compared to other biospecimens. In cancer research, blood samples are considered important as it aids in the prophecy of prognosis and determines responsively to systemic chemotherapy. Conversely, the use of whole blood specimens poses a challenge when united with microfluidic technology.

REGIONAL TAKEAWA

"North America region to dominate the industry throughout the forecast"

Depending on the region, the global industry is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. The North America CTC market is projected to dominate the industry throughout the forecast owing to the presence of major industry players and the availability of noninvasive & cost-effective biomarker tests in the region. On the other hand, the Asia Pacific region is estimated to grow at a lucrative rate by 2026 owing to growing awareness related to early detection of cancer and high unmet diagnostic needs in the region. In addition, the presence of technologically advanced infrastructure for cancer care and increasing market penetration rates are other factors responsible for the regional market growth.

COVID-19 IMPACT

The COVID-19 pandemic has progressively impacted the global circulating tumor cells market. Increasing morbidity and mortality rates due to cancer around the world is grabbing the attention of circulating tumor cells for the detection of cancer. The industry players are increasingly investing in R&D activities for cell-based research as people suffering from chronic diseases are more prone to caught COVID-19 disease. Moreover, the high usage rates of CTC technologies in cancer detection and biotechnology research developments are helping the overall market to sustain in these pandemic stress.

KEY VENDOR TAKEAWA

The leading players of the global circulating tumor cells market include Greiner Bio-One International GmbH, Bio-Techne Corporation, QIAGEN, Menarini Silicon Biosystems, Biocept, Inc., Sysmex Corporation, BioFluidica, ScreenCell, Rarecells Diagnostics, Fluxion Biosciences, Inc., Miltenyi Biotec, Precision for Medicine, ApoCell, Inc., Aviva Biosciences, BioCep, Ltd., Ikonysis, Inc., IVDiagnostics, NanoString Technologies, Inc., Canopus Bioscience Ltd., Biolidics Limited, Creatv MicroTech, Inc., LungLife AI, Inc., Epic Sciences, ScreenCell, Vitatex, Inc., Rarecells Diagnostics, and Bio-Techne Corporation.

These players are adopting several strategies such as partnerships, mergers & acquisitions, and collaborations to hold a strong position in the global industry. For instance, in March 2020, ANGLE PLC and BioView Ltd. entered into a collaboration to develop an integrated workflow for detecting clinical biomarkers on CTCs at the Molecular Med Tri-Con Conference held in San Francisco.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CIRCULATING TUMOR CELLS MARKET PLAYERS

ApoCell, Inc.

Aviva Biosciences

BioCep, Ltd.

Ikonysis, Inc.

QIAGEN

Menarini Silicon Biosystems

Biocept, Inc.

Sysmex Corporation

BioFluidica

ScreenCell

Fluxion Biosciences, Inc.

Miltenyi Biotec

Precision for Medicine

ScreenCell

Vitatex, Inc.

Rarecell Diagnostics

IVDiagnostics

NanoString Technologies, Inc.

Canopus Bioscience Ltd.

Biolidics Limited

Creatv MicroTech, Inc.

LungLife AI, Inc.

Epic Sciences

Greiner Bio One International GmbH

Bio-Techne Corporation

Bio-Techne Corporation

GLOBAL CIRCULATING TUMOR CELLS MARKET, BY TECHNOLOGY

CTC Analysis

CTC Direct Detection Methods

Microscopy

SERS

Others

CTC Detection & Enrichment Methods

Combined Methods

Density-based Separation (Label-free)

Size-based Separation (Label-free)

Membrane-based

Microfluidic-based

Immunocapture (Label-based)

Positive Selection

Negative Selection

GLOBAL CIRCULATING TUMOR CELLS MARKET, BY APPLICATION

Clinical/Liquid Biopsy

Screening and Monitoring

Risk Assessment

Research

Drug/Therapy Development

Cancer Stem Cell & Tumorigenesis Research

GLOBAL CIRCULATING TUMOR CELLS MARKET, BY PRODUCT

Kits & Reagents

Devices or Systems

Blood Collection Tubes

GLOBAL CIRCULATING TUMOR CELLS MARKET, BY SPECIMEN

Blood

Bone Marrow

Other Body Fluids

GLOBAL CIRCULATING TUMOR CELLS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. CIRCULATING TUMOR CELLS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Technology
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Product
    • 2.1.4. Market Snippet by Specimen
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. CIRCULATING TUMOR CELLS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. CIRCULATING TUMOR CELLS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. CIRCULATING TUMOR CELLS MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. CIRCULATING TUMOR CELLS MARKET - BY TECHNOLOGY

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
  • 6.2. CTC Analysis
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. CTC Direct Detection Methods
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1. Microscopy
      • 6.3.2.1.1. Overview
      • 6.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.2. SERS
      • 6.3.2.2.1. Overview
      • 6.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.3. Others
      • 6.3.2.3.1. Overview
      • 6.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. CTC Detection & Enrichment Methods
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.1. Combined Methods
      • 6.4.2.1.1. Overview
      • 6.4.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.2. Density-based Separation (Label-free)
      • 6.4.2.2.1. Overview
      • 6.4.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.3. Size-based Separation (Label-free)
      • 6.4.2.3.1. Overview
      • 6.4.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.3.2.1. Membrane-based
      • 6.4.2.3.2.1.1. Overview
      • 6.4.2.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.3.2.2. Microfluidic-based
      • 6.4.2.3.2.2.1. Overview
      • 6.4.2.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.4. Immunocapture (Label-based)
      • 6.4.2.4.1. Overview
      • 6.4.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.4.2.1. Positive Selection
      • 6.4.2.4.2.1.1. Overview
      • 6.4.2.4.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.4.2.4.2.2. Negative Selection
      • 6.4.2.4.2.2.1. Overview
      • 6.4.2.4.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. CIRCULATING TUMOR CELLS MARKET - BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 7.2. Research
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.2.2.1. Drug/Therapy Development
      • 7.2.2.1.1. Overview
      • 7.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.2.2.2. Cancer Stem Cell & Tumorigenesis Research
      • 7.2.2.2.1. Overview
      • 7.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Clinical/Liquid Biopsy
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.1. Screening and Monitoring
      • 7.3.2.1.1. Overview
      • 7.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.2. Risk Assessment
      • 7.3.2.2.1. Overview
      • 7.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. CIRCULATING TUMOR CELLS MARKET - BY PRODUCT

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
  • 8.2. Devices or Systems
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Blood Collection Tubes
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Kits & Reagents
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. CIRCULATING TUMOR CELLS MARKET - BY SPECIMEN

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
  • 9.2. Bone Marrow
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Blood
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Other Body Fluids
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. CIRCULATING TUMOR CELLS MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By Specimen, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By Specimen, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By Specimen, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By Specimen, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By Specimen, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Bio-Techne Corporation
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. Biocept, Inc.
  • 11.3. Sysmex Corporation
  • 11.4. Greiner Bio One International GmbH
  • 11.5. Precision for Medicine
  • 11.6. ApoCell, Inc.
  • 11.7. Aviva Biosciences
  • 11.8. BioCep, Ltd.
  • 11.9. Ikonysis, Inc.
  • 11.10. IVDiagnostics
  • 11.11. NanoString Technologies, Inc.
  • 11.12. Canopus Bioscience Ltd.
  • 11.13. Biolidics Limited
  • 11.14. Creatv MicroTech, Inc.
  • 11.15. LungLife AI, Inc.
  • 11.16. BioFluidica
  • 11.17. Rarecells Diagnostics
  • 11.18. Fluxion Biosciences, Inc.
  • 11.19. Miltenyi Biotec
  • 11.20. QIAGEN
  • 11.21. Menarini Silicon Biosystems
  • 11.22. Epic Sciences
  • 11.23. ScreenCell
  • 11.24. Vitatex, Inc.
  • 11.25. Rarecells Diagnostics
  • 11.26. Bio-Techne Corporation

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Circulating Tumor Cells market: Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Circulating Tumor Cells market, by Technology 2015-2026 (USD Million)
  • TABLE Circulating Tumor Cells market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Circulating Tumor Cells market, by Application 2015-2026 (USD Million)
  • TABLE Circulating Tumor Cells market: Product Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Circulating Tumor Cells market, by Product 2015-2026 (USD Million)
  • TABLE Circulating Tumor Cells market: Specimen Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Specimen
  • TABLE Global Circulating Tumor Cells market, by Specimen 2015-2026 (USD Million)
  • TABLE Circulating Tumor Cells market: Regional Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Circulating Tumor Cells market, by Region 2015-2026 (USD Million)
  • TABLE North America Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
  • TABLE North America Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
  • TABLE North America Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
  • TABLE North America Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
  • TABLE North America Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
  • TABLE Europe Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
  • TABLE Europe Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
  • TABLE Europe Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
  • TABLE Asia Pacific Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
  • TABLE Asia Pacific Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
  • TABLE Asia Pacific Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
  • TABLE Latin America Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
  • TABLE Latin America Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)

List of Figures

  • FIGURE Circulating Tumor Cells market segmentation
  • FIGURE Market Research Methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Technology segment market share analysis, 2019 & 2026
  • FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE CTC Analysis market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE CTC Direct Detection Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Microscopy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE SERS market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE CTC Detection & Enrichment Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Combined Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Density-based Separation (Label-free) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Size-based Separation (Label-free) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Membrane-based market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Microfluidic-based market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Immunocapture (Label-based) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Positive Selection market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Negative Selection market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Research market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Drug/Therapy Development market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cancer Stem Cell & Tumorigenesis Research market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Clinical/Liquid Biopsy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Screening and Monitoring market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Risk Assessment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Product segment market share analysis, 2019 & 2026
  • FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Devices or Systems market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Blood Collection Tubes market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Kits & Reagents market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Specimen segment market share analysis, 2019 & 2026
  • FIGURE Specimen segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Bone Marrow market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Blood market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Other Body Fluids market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Circulating Tumor Cells market share and leading players, 2018
  • FIGURE Europe Circulating Tumor Cells market share and leading players, 2018
  • FIGURE Asia Pacific Circulating Tumor Cells market share and leading players, 2018
  • FIGURE Latin America Circulating Tumor Cells market share and leading players, 2018
  • FIGURE Middle East and Africa Circulating Tumor Cells market share and leading players, 2018
  • FIGURE North America Circulating Tumor Cells market share analysis by country, 2018
  • FIGURE U.S. Circulating Tumor Cells Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Circulating Tumor Cells Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Circulating Tumor Cells Market share analysis by country, 2018
  • FIGURE Germany Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Circulating Tumor Cells market share analysis by country, 2018
  • FIGURE India Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Circulating Tumor Cells market share analysis by country, 2018
  • FIGURE Brazil Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Circulating Tumor Cells market share analysis by country, 2018
  • FIGURE Saudi Arabia Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)